Daniel Martel

skip to Main Content
skip to Footer

Martel, Daniel

daniel.martel@lw.com

+33.1.40.62.20.82

Profile

Daniel Martel is an associate in the Paris office of Latham & Watkins and a member of the Corporate Department. He primarily advises clients on complex commercial transactions and technology/IP-related transactions. Daniel has developed his practice in a broad range of sectors including media, sport and entertainment, luxury, retail, financial, telecommunications, aerospace and defense, energy, and life sciences.

Experience

Daniel's experience includes advising:

TA Associates on the joint acquisition, alongside Montagu Private Equity, of Harvest, a leading fintech in France for software dedicated to the wealth and finance professions
L’Oréal on the acquisition of a minority stake in Galderma, the pure-play dermatology category leader
A global medical device leader on the US$50 million series D financing round of TriCares, a French medtech startup
Imerys on the disposal of its assets serving the paper market to an affiliate of Flacks Group, a US investment firm, for a net equity value close to €150 million

Qualifications

Bar Qualification

Avocat (Paris)
New York

Education

LLM in Intellectual Property, Fordham University School of Law
Masters of Law in IP/IT Law, University of Paris - Sud
Masters in Business Law, University Pantheon-Assas Paris II
Bachelor in Civil Law, University Paris 2 Panthéon-Assas Law School

Languages Spoken

French
English
Spanish

Practices

Industries

August 5, 2024 Our Work

Latham Advises L’Oréal on Acquisition of Minority Stake in Galderma

Paris team represents the world’s leading beauty player on the transaction.

Biopharma GettyImages-523791776.jpg

July 31, 2024 Our Work

Latham Advises Global Medical Device Leader on US$50 Million Series D Fundraising of TriCares

Cross-border team advises firm on strategic investment in French medtech startup.

July 15, 2024 Our Work

Latham Advises Imerys on Disposal of Assets Serving the Paper Market

May 24, 2024 Our Work

Latham Advises Samsung Medison on Acquisition of Sonio

May 10, 2024 Our Work

Latham Advises Goldman Sachs Alternatives on Acquisition of Majority Stake in Crystal

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.